argenx to Present at Upcoming Investor Conferences
argenx (Nasdaq: ARGX), a global immunology company, has announced its management team's participation in two upcoming investor conferences in September 2025. The company will present at the 2025 Wells Fargo Healthcare Conference on September 4 at 8:00 a.m. ET in Boston, and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 8 at 7:00 a.m. ET in New York.
Investors can access live webcasts of both presentations through the Investors section of argenx's website, with replays available for approximately 30 days after each event.
argenx (Nasdaq: ARGX), azienda globale nel campo dell'immunologia, ha comunicato che il suo team dirigenziale parteciper脿 a due conferenze per investitori previste a settembre 2025. L'azienda terr脿 una presentazione al 2025 Wells Fargo Healthcare Conference il 4 settembre alle 8:00 ET a Boston e al Morgan Stanley 23rd Annual Global Healthcare Conference l'8 settembre alle 7:00 ET a New York.
Gli investitori potranno seguire entrambe le presentazioni in diretta tramite la sezione 'Investors' del sito di argenx; le registrazioni saranno disponibili in replay per circa 30 giorni dopo ciascun evento.
argenx (Nasdaq: ARGX), una compa帽铆a global de inmunolog铆a, ha anunciado la participaci贸n de su equipo directivo en dos conferencias para inversores que se celebrar谩n en septiembre de 2025. La compa帽铆a realizar谩 una presentaci贸n en el 2025 Wells Fargo Healthcare Conference el 4 de septiembre a las 8:00 a.m. ET en Boston, y en el Morgan Stanley 23rd Annual Global Healthcare Conference el 8 de septiembre a las 7:00 a.m. ET en Nueva York.
Los inversores podr谩n acceder a las retransmisiones en directo de ambas presentaciones a trav茅s de la secci贸n 'Investors' en la web de argenx; las repeticiones estar谩n disponibles durante aproximadamente 30 d铆as tras cada evento.
argenx (Nasdaq: ARGX), 旮�搿滊矊 氅挫棴頃� 旮办梾鞚� 鞛愳偓鞚� 瓴届榿歆勳澊 2025雲� 9鞗旍棎 鞐措Μ電� 霊� 瓯挫潣 韴瀽鞛� 旎嵓霟办姢鞐� 彀胳劃頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 2025 Wells Fargo Healthcare Conference鞐愳劀 9鞗� 4鞚� 氙戈淡 霃欕秬鞁滉皠 鞓れ爠 8鞁�(氤挫姢韯�) 氚滍憸毳� 歆勴枆頃橁碃, Morgan Stanley 23rd Annual Global Healthcare Conference鞐愳劀電� 9鞗� 8鞚� 氙戈淡 霃欕秬鞁滉皠 鞓れ爠 7鞁�(雺挫殨)鞐� 氚滍憸頃╇媹雼�.
韴瀽鞛愲摛鞚� argenx 鞗轨偓鞚错姼鞚� 'Investors' 靹轨厴鞚� 韱淀暣 霊� 氚滍憸鞚� 鞁れ嫓臧� 鞗轨簮鞀ろ姼毳� 鞁滌箔頃� 靾� 鞛堨溂氅�, 臧� 頄夓偓 頉� 鞎� 30鞚缄皠 雼れ嫓氤搓赴(replay)毳� 鞝滉车氚涭潉 靾� 鞛堨姷雼堧嫟.
argenx (Nasdaq: ARGX), soci茅t茅 internationale en immunologie, a annonc茅 la participation de son 茅quipe de direction 脿 deux conf茅rences investisseurs en septembre 2025. La soci茅t茅 pr茅sentera au 2025 Wells Fargo Healthcare Conference le 4 septembre 脿 8h00 ET 脿 Boston, et au Morgan Stanley 23rd Annual Global Healthcare Conference le 8 septembre 脿 7h00 ET 脿 New York.
Les investisseurs pourront suivre les deux pr茅sentations en direct via la rubrique 'Investors' du site d'argenx ; les rediffusions seront disponibles pendant environ 30 jours apr猫s chaque 茅v茅nement.
argenx (Nasdaq: ARGX), ein weltweit t盲tiges Immunologie-Unternehmen, hat angek眉ndigt, dass sein Managementteam im September 2025 an zwei Investorenkonferenzen teilnehmen wird. Das Unternehmen wird am 2025 Wells Fargo Healthcare Conference am 4. September um 8:00 Uhr ET in Boston pr盲sentieren und am Morgan Stanley 23rd Annual Global Healthcare Conference am 8. September um 7:00 Uhr ET in New York.
Investoren k枚nnen beide Pr盲sentationen live 眉ber den Bereich 'Investors' auf der argenx-Website verfolgen; Wiederholungen sind jeweils etwa 30 Tage nach der Veranstaltung verf眉gbar.
- None.
- None.
August 28, 2025
Amsterdam, the Netherlands 鈥� argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of the management team will participate in the following investor conferences in September:
- 2025 Wells Fargo Healthcare Conference. Fireside chat on Thursday, September 4, 2025 at 8:00 a.m. ET in Boston, MA.
- Morgan Stanley 23rd Annual Global Healthcare Conference. Fireside chat on Monday, September 8, 2025 at 7:00 a.m. ET in New York, NY.
A live webcast of the presentations may be accessed on the Investors section of the argenx website at . A replay of the webcasts will be available on the argenx website for approximately 30 days following the presentation.
About argenx
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker and is evaluating its broad potential in multiple serious autoimmune diseases while advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit聽聽and follow us on聽,听,听, and聽.
Contacts
Media:
Ben Petok
Investors:
Alexandra Roy
FAQ
When is argenx (ARGX) presenting at the Wells Fargo Healthcare Conference 2025?
What time is argenx's presentation at the Morgan Stanley Healthcare Conference 2025?
How can investors access argenx's (ARGX) conference presentations?
What type of company is argenx (ARGX)?
